PlainRecalls
FDA Drug Moderate Class II Terminated

Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.

Reported: January 17, 2024 Initiated: December 20, 2023 #D-0221-2024

Product Description

Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.

Reason for Recall

CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

Details

Units Affected
100=29,184 bottles; 500=2922 bottles
Distribution
Product was distributed nationwide.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 100=29,184 bottles; 500=2922 bottles.
Why was this product recalled?
CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 17, 2024. Severity: Moderate. Recall number: D-0221-2024.